Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome

C Juhasz1, C E A Batista, D C Chugani

  • 1Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, 3901 Beaubien Boulevard, Detroit, MI, USA. juhasz@pet.wayne.edu

Insights

Sturge-Weber syndrome (SWS) shows progressive brain metabolism changes before age 3, linked to increased seizure frequency. Some children experience metabolic recovery, suggesting a therapeutic window for SWS treatment.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Medical Imaging

Background:

  • Sturge-Weber syndrome (SWS) natural course and neurological progression are not well understood.
  • Early SWS neurological symptoms are often progressive.

Purpose of the Study:

  • To track longitudinal changes in brain glucose metabolism using PET scans in children with SWS.
  • To correlate metabolic changes with clinical progression in early SWS.

Main Methods:

  • 14 children with SWS underwent two PET scans over a mean follow-up of 1.2 years.
  • Assessed longitudinal changes in cortical glucose hypometabolism extent.
  • Correlated metabolic changes with age, seizure frequency, and hemiparesis.

Main Results:

  • Progressive hypometabolism enlargement occurred in 6 younger children, associated with higher seizure frequency.
  • Metabolic changes correlated with age-related increases in unaffected cortex metabolism.
  • Two children showed decreased hypometabolism, one with hemiparesis resolution.

Conclusions:

  • Detrimental metabolic changes in SWS occur before age 3, coinciding with increased cerebral metabolic demand.
  • Progressive hypometabolism is linked to high seizure frequency in SWS.
  • Partial metabolic recovery with neurological improvement suggests a therapeutic window in unilateral SWS.
Abstract

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...